Profilo
Michael Hamill is currently an Origination Partner at Flagship Pioneering, Inc. since 2025.
Formerly, Dr. Hamill was Vice President-Research at Axcella Health, Inc. from 2011 to 2021.
Dr. Hamill earned a doctorate from Boston University and completed undergraduate degrees at Gettysburg College.
Posizioni attive di Michael Hamill
| Società | Posizione | Inizio |
|---|---|---|
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Investitore di Private Equity | 01/07/2021 |
Precedenti posizioni note di Michael Hamill
| Società | Posizione | Fine |
|---|---|---|
| AXCA HEALPAR | Corporate Officer/Principal | 01/06/2021 |
Formazione di Michael Hamill
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Gettysburg College
Gettysburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axcella Health, Inc.
Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
















